Latest European Commission analysis charts worries over falling levels of investment and weak university-business transfers

MEPs say there is a “lack of clarity and comparability of the figures put forward” by the EU executive

The era of prescription digital health has dawned with approval of an app assessed to the same standard of clinical evidence as a conventional drug. Now pharma companies and digital therapy pioneers are forging development and marketing deals, while EU regulators and payers flounder

Automated surveillance was 100% accurate, while experts relying on manual recording and interpretation of individual patient data made errors. The automated system is faster and can be programmed to run checks at any timea

Using anonymised information from electronic health records is an efficient and low-cost way of following up subjects years after the treatment phase of a study completes

Older adults in England with fewer financial resources are more likely to develop dementia, according to new research.

Machine learning shown to detect one of the commonest causes of dementia and stroke more accurately than current methods

The class of 2019 will be welcomed in Vienna if agreement with the Hungarian government is not reached soon, the university’s pro-rector tells Science|Business

New drafts of next research programme reveal efforts to hold the line between competing demands of industry and civil society bodies. And there are mixed messages on the future of graphene and human brain projects

The seal of excellence is as much a signifier of the EU’s R&D funding shortfall as it is of Europe’s high quality science. Now, the EU wants money from the cohesion programme to fill the funding gap and translate research to market